Companies / Amicus Therapeutics Inc
Amicus Therapeutics Inc
Financials · FY2025
Ownership
314.0M shares outstanding · as of Feb 12, 2026
Ownership
| 10%+ / strategic | 19.71% | 61,876,043 |
| Institutions | 100.87% | 316,738,093 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 14
View all →| Insider | % of shares | Shares |
|---|---|---|
Bleil Lynn DorseyDirector | 0.00% | 0 |
Campbell Bradley LCEOPresident and CEO · Director | 0.00% | 0 |
Castelli JeffChief Development Officer | 0.00% | 0 |
Clark David MichaelChief People Officer | 0.00% | 0 |
Harford Simon N.R.Chief Financial Officer | 0.00% | 0 |
Kelly Michael AaronDirector | 0.00% | 0 |
McGlynn Margaret GDirector | 0.00% | 0 |
Prout SamanthaChief Accounting Officer | 0.00% | 0 |
Raab MichaelDirector | 0.00% | 0 |
Roberts EiryDirector | 0.00% | 0 |
Institutional holders 340
View all →| Holder | Value | % of shares |
|---|---|---|
| $463.15M | 10.36% | |
| $422.97M | 9.46% | |
| $211.23M | 4.72% | |
| $163.76M | 3.66% | |
| $152.87M | 3.42% | |
| $151.34M | 3.38% | |
| $127.01M | 2.80% | |
| $123.45M | 2.72% | |
| $114.36M | 2.52% | |
| $90.72M | 2.03% |
Activity
Mar 31, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Exit | Common stock | $-463.15M | -32.5M -100.00% | 0 | high |
| Q4 2025 as of | Hbk Investments L P 13F manager | New | Common stock | $217.16M | +15.3M | 15,250,000 4.86% of shares | high |
| Q2 2026 as of | State Street Corporation 13F manager | Exit | Common stock | $-211.23M | -14.8M -100.00% | 0 | high |
| Q1 2026 as of | Hbk Investments L P 13F manager | Trim | Common stock | $-93.51M | -6.5M -42.40% | 8,783,448 2.80% of shares | high |
| Q1 2026 as of | Perceptive Advisors LLC 13F manager | Exit | Common stock | $-90.72M | -6.4M -100.00% | 0 | high |
| Q1 2026 as of | Millennium Management LLC 13F manager | Add | Common stock | $71.05M | +4.9M +164.05% | 7,908,459 2.52% of shares | high |
| Q1 2026 as of | Palo Alto Investors LP 13F manager | Trim | Common stock | $-59.18M | -4.1M -78.62% | 1,113,045 0.35% of shares | high |
| Q1 2026 as of | Weiss Asset Management LP 13F manager | New | Common stock | $56.00M | +3.9M | 3,872,902 1.23% of shares | high |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| William Blair Investment Management, LLC | Passive13G/A | — |
| Wellington Management Group LLP | Passive13G/A | — |
| Glazer Capital, LLC | Passive13G | — |
| Vanguard Capital Management | Passive13G | — |
| UBS Group AG | Passive13G | — |
| The Goldman Sachs Group, Inc. | Passive13G | — |
| Barclays PLC | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| FOLD | — | 03152W109 |